LILRB1 polymorphism and surface phenotypes of natural killer cells

被引:31
作者
Davidson, Chelsea L. [1 ]
Li, Nicholas L. [1 ]
Burshtyn, Deborah N. [1 ]
机构
[1] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada
基金
加拿大健康研究院;
关键词
Leukocyte receptor complex; LILRB1; polymorphism; Natural killer cells; Inhibitory receptor; CLASS-I MOLECULES; INHIBITORY RECEPTOR; TRANSCRIPT-2; ILT2; TARGET-CELLS; HOMOLOG UL18; BINDING; LIR-1; INFECTION; DISEASE; ANTIGEN;
D O I
10.1016/j.humimm.2010.06.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Leukocyte Ig-like receptor (LIR)-1 is an inhibitory receptor that binds a broad range of class I HLA molecules and is encoded by the LILRB1 gene within the leukocyte receptor complex. In contrast to uniform expression on monocytes and B cells, LIR-1 expression on natural killer (NK) cells varies considerably between individuals. To investigate how polymorphism is related to the observed patterns of expression, we analyzed the LILRB1 gene and its transcriptional activity in a group of individuals with various levels of expression on NK cells. We found that LILRB1 transcription is correlated with surface protein expression on NK cells. In a cohort of 24 donors, we found high expression on NK cells to be associated with three linked SNPs (AGG verses GM) within the putative regulatory region. We also identified several new protein variants and observed variants with P, T, T, and 1 at positions 68, 95, 142, and 155, respectively, more frequently in donors with low expression on NK cells. These results suggest that there is a significant degree of diversity within the LILRB1 locus and that it influences expression patterns on NK cells. These genetic differences may underpin variation in individual immune responses involving LIR-1 on NK cells. (C) 2010 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:942 / 949
页数:8
相关论文
共 34 条
  • [1] Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily
    Banham, AH
    Colonna, M
    Cella, M
    Micklem, KJ
    Pulford, K
    Willis, AC
    Mason, DY
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (06) : 841 - 845
  • [2] The LILR family: modulators of innate and adaptive immune pathways in health and disease
    Brown, D
    Trowsdale, J
    Allen, R
    [J]. TISSUE ANTIGENS, 2004, 64 (03): : 215 - 225
  • [3] The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18
    Chapman, TL
    Heikema, AP
    Bjorkman, PJ
    [J]. IMMUNITY, 1999, 11 (05) : 603 - 613
  • [4] Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2)
    Chapman, TL
    Heikema, AP
    West, AP
    Bjorkman, PJ
    [J]. IMMUNITY, 2000, 13 (05) : 727 - 736
  • [5] Colonna M, 1998, J IMMUNOL, V160, P3096
  • [6] DENNEY L, 2010, PLOS ONE, V115, P3278
  • [7] Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization
    Dietrich, J
    Cella, M
    Colonna, M
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (04) : 2514 - 2521
  • [8] Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO
  • [9] 2-2
  • [10] Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1
    Gazit, R
    Gruda, R
    Elboim, M
    Arnon, TI
    Katz, G
    Achdout, H
    Hanna, J
    Qimron, U
    Landau, G
    Greenbaum, E
    Zakay-Rones, Z
    Porgador, A
    Mandelboim, O
    [J]. NATURE IMMUNOLOGY, 2006, 7 (05) : 517 - 523